Clinical Trials · NCT00086619

Parathyroid Hormone (PTH) for Osteoporosis in Postmenopausal Women

CompletedPhase 2Teriparatide (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
Massachusetts General Hospital
Enrollment
80
Start date
May 2004
Locations
1 site, United States
Primary endpoint
Changes in Indices of Bone Turnover
View Teriparatide compound reference